Elevance Health beats estimates, raises guidance
Published . Updated .
Elevance Health beats estimates, raises guidance Investing.com
Directly affected
- ELV Elevance Health
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
A fund of health-care companies
- XBI SPDR S&P Biotech
A fund of biotechnology companies
- UNH UnitedHealth
A large health insurer
- JNJ Johnson & Johnson
A large health-care company
- LLY Eli Lilly
A large drug maker
- PFE Pfizer
A large drug maker
Price reaction, T-5 to T+3
Elevance Health beats estimates, raises guidance Investing.com
Source: Investing.com
How solid “Elevance Health beats estimates, raises guidance” looks
12 out of 100
“Elevance Health beats estimates, raises guidance” scores 12 out of 100. The score uses 1 sources.